Nursing Perspectives on the Impact of Immune Checkpoint Inhibitors in Early Stages of Cancer
Download these slides from a live webinar to gain more expert insight on the role of immune checkpoint inhibitors in early stages of cancer and how to optimally prevent, mitigate, and manage associated immune-related adverse events.
Associate Professor Yale School of Nursing Senior Advanced Practice Nurse Smilow Cancer Hospital at Yale New Haven Yale Comprehensive Cancer Center New Haven, Connecticut
Ronan J. Kelly, MD, MBA
Director, Charles A. Sammons Cancer Center W.W. Caruth Jr. Endowed Chair of Immunology Baylor University Medical Center Chief, Oncology Baylor Scott & White Health System (NTx) Clinical Professor Texas A&M University College of Medicine Dallas, Texas
Provided by Clinical Care Options, LLC
Supported by an educational grant from Bristol Myers Squibb.
Bristol Myers Squibb
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.